C-Bond Systems, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Deficit (Details)

Shareholders' Deficit (Details) - USD ($)								1 Months Ended					3 Months Ended		12 Months Ended
Shareholders' Deficit (Details) - USD ($)	Mar. 08, 2021	Feb. 01, 2021	Jan. 18, 2021	Jan. 07, 2021	Jan. 06, 2021	Jan. 13, 2020	Dec. 12, 2019	Mar. 19, 2021	Feb. 24, 2021	Aug. 20, 2020	Feb. 20, 2020	Feb. 18, 2020	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Shareholders' Deficit (Details) [Line Items]
Accrued dividend payable													$ 3,286
Common shares per share (in Dollars per share)						$ 0.04
Stock-based professional fees													224,753	$ 136,541
Prepaid expenses													38,250
Stock-based professional fees													43,250
Accretion of stock-based professional fees													5,000
Issued shares of common stock (in Shares)				1,008,000
Stock-based compensation expense on granted non-vested													108,554	$ 170,072
Unrecognized compensation expense													177,696
Shares of common stock upon conversion (in Shares)						151,456								475,000
Accounts payable						$ 6,058
Accrued interest														$ 12,220
Net of fees														500
Cashless exercise of warrants (in Shares)				1,050,000
Compensation expense related to stock options													0	191,308
Total unrecognized compensation expense related to unvested stock options													$ 0
Warrant purchase, description				the Company issued 1,008,000 shares of its common stock in connection with the cashless exercise of 1,050,000 warrants. The exercise price was based on contractual terms of the related warrant.
2018 Long-Term Incentive Plan [Member]
Shareholders' Deficit (Details) [Line Items]
Stock option, description													the Company’s common stock that may be subject to incentive stock options granted under the 2018 Plan is 50,000,000 shares, of which 11,445,698 shares have been issued or granted under incentive stock options and 25,951,070 shares of restricted stock have been issued as of March 31, 2021.
Aggregate shares of common stock (in Shares)													25,000,000
Description of options to acquire common stock													The exercise price of options granted under our 2018 Plan must at least be equal to the fair market value of the Company’s common stock on the date of grant and the term of an option may not exceed ten years, except that with respect to an incentive stock option granted to any employee who owns more than 10% of the voting power of all classes of the Company’s outstanding stock as of the grant date the term must not exceed five years and the exercise price must equal at least 110% of the fair market value on the grant date.
Business Development [Member]
Shareholders' Deficit (Details) [Line Items]
Common shares per share (in Dollars per share)	$ 0.066	$ 0.078			$ 0.10
Shares of grant restricted stock award of common shares (in Shares)					100,000
Value of grant restricted stock award of common shares	$ 49,500	$ 54,600			$ 10,000
Stock-based professional fees	20,167	$ 16,900			$ 10,000
Prepaid expenses	$ 29,333
Aggregate shares of common stock (in Shares)	750,000	700,000
Workers' Compensation Insurance [Member]
Shareholders' Deficit (Details) [Line Items]
Prepaid expenses		$ 37,700
Consulting Agreement [Member]
Shareholders' Deficit (Details) [Line Items]
Common shares per share (in Dollars per share)											$ 0.04
Shares of grant restricted stock award of common shares (in Shares)											1,250,000
Value of grant restricted stock award of common shares											$ 50,000
Stock-based professional fees														8,334
Prepaid expenses														$ 41,666
General Release Agreement [Member]
Shareholders' Deficit (Details) [Line Items]
Accrued compensation								$ 40,625
Common shares per share (in Dollars per share)								$ 0.059
Issued shares of common stock (in Shares)								944,767
Value of issued shares of common stock								$ 55,741
Stock-based compensation								$ 15,116
Investor [Member]
Shareholders' Deficit (Details) [Line Items]
Purchase of shares (in Shares)						7,000,000						7,000,000
Cash proceeds from investor						$ 280,000						$ 280,000
Common shares per share (in Dollars per share)						$ 0.04						$ 0.04
Sales Manager [Member]
Shareholders' Deficit (Details) [Line Items]
Common shares per share (in Dollars per share)		$ 0.078
Issued shares of common stock (in Shares)		200,000
Value of issued shares of common stock		$ 15,600
Vested date		May 01, 2022
Stock-based compensation		$ 15,600
Officer [Member]
Shareholders' Deficit (Details) [Line Items]
Common shares per share (in Dollars per share)	$ 0.066
Shares of grant restricted stock award of common shares (in Shares)	2,500,000
Value of grant restricted stock award of common shares	$ 165,000
Vested date	May 01, 2022
Series B Preferred Stock [Member]
Shareholders' Deficit (Details) [Line Items]
Designations established share (in Shares)							100,000
Preferred Stock par value (in Shares)							0.10
Stated value							$ 1,000
Preferred Stock dividend Rate							2.00%
Stock option, description							The Series B is convertible into common stock at the option of a holder or if the closing price of the common stock exceeds 400% of the Conversion Price for a period of twenty consecutive trading days, at the option of the Company. Conversion Price means a price per share of the common stock equal to 100% of the lowest daily volume weighted average price of the common stock during the two years preceding or subsequent two years following the Issuance Date, subject to adjustment as otherwise provided in the Certificate of Designations (the “Conversion Price”).
Accrued compensation			$ 295,000
Accrued compensation shares (in Shares)			295
Stock based compensation			$ 3,778,810
Accrued dividend payable													$ 5,762		$ 2,476
Preferred stock balance													727,732		429,446
Liquidation value													721,970		426,970
Series C Preferred Stock [Member]
Shareholders' Deficit (Details) [Line Items]
Designations established share (in Shares)										100,000
Preferred Stock par value (in Shares)										0.10
Stated value										$ 100					1,330,000
Preferred Stock dividend Rate										2.00%
Accrued dividend payable													13,083		6,031
Preferred stock balance													1,593,083		$ 1,336,031
Liquidation value													1,580,000
Percentage of stated value										150.00%
Series C Convertible Preferred Stock [Member]
Shareholders' Deficit (Details) [Line Items]
Accrued dividend payable									$ 2,845,238				$ 7,052
Purchase of shares (in Shares)									2,500
Series C Convertible Preferred Stock [Member] \| Maximum [Member]
Shareholders' Deficit (Details) [Line Items]
Stated value									$ 250,000
Series C Convertible Preferred Stock [Member] \| Minimum [Member]
Shareholders' Deficit (Details) [Line Items]
Stated value									$ 100.00